Skip to main content

Advertisement

Open Peer Review Reports for: Influence of afatinib dose on outcomes of advanced EGFR-mutant NSCLC patients with brain metastases

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
30 Aug 2018 Submitted Original manuscript
22 Sep 2018 Reviewed Reviewer Report - Chi-Lu Chiang
22 Sep 2018 Reviewed Reviewer Report - Sreenivasan Sasidharan
21 Oct 2018 Author responded Author comments - Wan Ling Tan
Resubmission - Version 2
21 Oct 2018 Submitted Manuscript version 2
11 Nov 2018 Author responded Author comments - Wan Ling Tan
Resubmission - Version 3
11 Nov 2018 Submitted Manuscript version 3
19 Nov 2018 Author responded Author comments - Wan Ling Tan
Resubmission - Version 4
19 Nov 2018 Submitted Manuscript version 4
Publishing
20 Nov 2018 Editorially accepted
3 Dec 2018 Article published 10.1186/s12885-018-5110-2

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement